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Recently, a mumps outbreak in New York and New Jersey was reported by the Centers for Disease Control and Prevention (CDC).
Subsequently, the dissemination of the disease was rapid, and, from June 28th 2009 through January 29th 2010, a total of 1,521
cases of mumps were reported in New York and New Jersey. Seven presumed cases occurred in pregnant women cared for at
our institution. Mumps diagnosis as per the NYC Department of Health and Mental Hygiene was based on clinical manifestations,
particularlyparotitis.PriorimmunizationswithmumpsvaccineandnegativeIgMwerenotadequatetoruleoutmumpsinfections.
All of our seven patients had exposure to mumps in either their household or their community, and some of the them had
symptoms of mumps. Due to the diﬃculties in interpreting serologies of these patients, their cases led to a presumed diagnosis of
mumps. The diagnosis of mumps lead to the isolation of patients and health care personnel that were in contact with them. In this
paper, we detail the presenting ﬁndings, diagnostic dilemmas and infection control challenges associated with presumed cases of
mumps in pregnancy.
1.Introduction
Mumps is an acute infectious disease, caused by an RNA pa-
ramyxovirus. Humans are the only natural hosts, and the
virus is spread by contact with infected respiratory droplets.
Patients with mumps are usually contagious for two days
prior to gland swelling and up to ﬁve days after the swell-
ing appears. The course of mumps tends to begin with non-
speciﬁc symptoms such as myalgia, headaches, anorexia,
malaise, and high fever. Unilateral or bilateral parotid gland
enlargementtendstopresent24hoursafterinitialsymptoms.
Typical acute parotitis occurs in only about 30–40% of cases,
while 15–20% of infections are completely asymptomatic,
and up to 50% of infections are associated with nonspeciﬁc
or primary respiratory symptoms. Inapparent infection or
completelyasymptomaticmumpsinfectionmorecommonly
occur in adults than in children [1].
Although disease is generally mild and self-limited, oc-
casional complications may ensue; ten percent of patients
develop aseptic meningitis, and less common complications
include encephalitis, permanent deafness, orchitis, and pan-
creatitis [2]. Vaccination has been key to the prevention of
those complications, and, as of 1998, 82 countries had estab-
lished childhood immunization programs [3]. Over the last
several decades, there have been few reports of mumps epi-
demics in the United States (US).
Recently, a mumps outbreak in New York and New Jersey
was reported by the Centers for Disease Control and Preven-
tion (CDC) [4]. The index patient was an 11-year-old boy
whotraveledtotheUnitedKingdom, whereoverseventhou-
sandcasesofmumpshavebeenreportedsince2004[5].After
his return to the US, the patient traveled to a summer camp
forobservantJewishboysinupstateNewYork.Subsequently,
the dissemination of the disease was rapid, and from June
28th2009throughJanuary29th2010,atotalof1,521casesof
mumpswerereportedinN ewY orkandN ewJ ersey[4].Seven
presumed cases occurred in pregnant women cared for at
o u ri n s t i t u t i o n .I nt h i sp a p e r ,w er e p o rtt h i ss e r i e so fw o m e n ,2 Infectious Diseases in Obstetrics and Gynecology
discuss lessons learned from their care, and review the recent
literature. We highlight the diﬃculty in making deﬁnitive
diagnoses, the limitations of serology and vaccination, and
the potential adverse impact on staﬃng consequent to ex-
posure to presumed cases.
2.Cases
Between August 2009 and early January 2010, 40 cases
of conﬁrmed or suspected mumps were seen at Maimon-
idesMedicalCenter,sevenofwhomwerewomenintheante-
partum, intrapartum, or postpartum period. Per the rec-
ommendations of the New York City Department of Health
and Mental Hygiene (NYC DOHMH), the case deﬁnition
of mumps included anyone who presented with the acute
onset of unilateral or bilateral tender, self-limited, swelling
of parotid, or other salivary glands lasting two or more days
without other apparent cause [6]. Additionally, all women
presenting to the obstetrical triage area during the outbreak
were asked about recent exposure to mumps. This strate-
gy was based in large part on the failure of serostatus to ac-
curatelyreﬂectimmunestatus,andtheknownfailureratesof
vaccine (vide infra). Thus, in a community in the midst of an
epidemic, any patient who lived in the borough of Brooklyn,
and who had neck swelling without other apparent cause,
was considered to have mumps [7].
The ﬁrst case was a 31-year-old multiparous woman who
presented in labor at 35-weeks gestation with spontaneous
rupture of membranes. During the initial examination, the
patient reported that she had been diagnosed with mumps a
few weeks earlier after one of her sons presented with symp-
toms. Since we could not conﬁrm her diagnosis, and we
did not know the date of her last exposure, a decision was
made to place the patient in a private room with droplet pre-
cautions, and she was induced with cervidil. After delivery,
the patient was continued on droplet precautions. No con-
ﬁrmatory testing was performed since it would not have af-
fected management. The second patient, a 45-year-old para
13, presented to the hospital at 39-weeks gestation for a
repeat cesarean section. On postpartum day three, she com-
plained of parotid gland swelling. As per the patient, she
did not have any known contact with any individuals with
mumps. The patient was afebrile but had parotid gland ten-
derness. The patient was placed on droplet precautions. Sub-
sequent serum mumps IgM antibody was negative and IgG
was 2.37 (immune).
The third patient, a 38 year old para 12 at 41 weeks
and one-day gestation, was seen in labor and delivery in
active labor and reported that she had been diagnosed with a
mumps infection by her PMD three days prior, based upon
her clinical presentation. The patient was placed on drop-
let precautions, given a face mask to be used when in con-
tact with her infant, and was discharged home two days
postpartum. In this case, mumps IgG and IgM levels were
not sent because she had previously been diagnosed, and her
management would not have been aﬀected. The fourth pa-
tient, a 37 year old para 5 at term, presented to labor and
delivery in active labor. Two days postpartum, the patient
complained of swelling of her jaw and tenderness. She
reported that a diagnosis of mumps had been suspected in
her 10-year-old son a few days earlier. Blood drawn at the
time of symptom onset subsequently returned as IgG 2.27
and IgM negative. During the investigation period, the pa-
tient was placed on droplet precautions and monitored
closely. The ﬁfth patient, a 29 year old para six at 37-weeks
and 5-days gestation, presented to labor and delivery with
signs of preeclampsia. The patient was given magnesium and
induced with cervidil. The patient reported that three of her
children at home were diagnosed with mumps. She com-
plained of weakness and had parotid gland tenderness and
swelling, and a mild fever. The patient was placed on drop-
let precautions. The IgG antibody was 2.43, and IgM was
negative. She delivered 24 hours after her admission and was
d i s c h a r g e dh o m eaf e wd a y sl a t e r .
Two additional pregnant patients with suspected mumps
infection were seen in the emergency room (ER), one at 32
weeks of gestation and the other at 10 weeks of gestation.
The ﬁrst was a 24 year old para 1 in the third trimester,
who presented with URI symptoms, diﬃculty swallowing,
and parotid gland tenderness. She was discharged home with
precautions. Mumps IgG antibody was 1.13, and IgM was
negative. The second patient was a 22 year old para 1 in the
ﬁrst trimester who presented with nausea and vomiting. The
patient reported that she had been diagnosed with mumps
by her physician one week previously. While in the ER, she
was placed on droplet precautions, given IV hydration and
ondansetron, and was discharged home a few hours later.
In all cases, providers who had been in contact with the
source patients before the patients were placed on droplet
precautions were queried about their immunization status.
If they did not have evidence of two prior MMRs, a physician
documented history of mumps or serologic evidence of
immunity, mumps IgG testing was performed. While the
results were pending, they were furloughed. If the serology
results were negative, they were removed from the workplace
for the entire incubation period, from days 12 through 25
after exposure. For a brief period during the outbreak, the
NYC DOHMH did not consider serologic evidence of IgG to
be a marker of immunity and recommended that exposed
employees unable to produce proof of receipt of 2 MMR
vaccines or a physician documented history of mumps be
furloughed for the incubation period.
3. Discussion
During the outbreak period, the NYC DOHMH recom-
mended that all patients be screened for symptoms of
m u m p sa sw e l la sf o rah i s t o r yo fr e c e n te x p o s u r ea tt h et i m e
of admission. This was essential for preventing transmission
ofmumpstopatientsandstaﬀwithinthehospital.Wereport
a series of obstetrical patients who were suspected of having
mumps or who had recent exposure during that epidemic.
For reasons discussed below, all cases were diagnosed based
on clinical presentation, independent of IgG or IgM levels.
Postpartum mothers who were suspected of having mumps
were advised to wear a mask within 3–6 feet of their infants.
Partofthediﬃcultyinmanagingthesecaseswasthereal-
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is an inexact predictor of an individual’s mumps immune
status. Current mumps immunization recommendations are
for a ﬁrst dose of Measles Mumps Rubella (MMR) vaccine
at age 12–15 months and a second dose between the ages
of four and six. A child is considered to have adequate im-
munity when there has been documented administration of
two doses of live virus vaccine or laboratory evidence of im-
munity to disease. The eﬀectiveness of mumps vaccine has
been estimated to be 73–91% after the ﬁrst dose of vac-
cine, and 76–95% after two doses of vaccine. [8]H o w e v e r ,
recent mumps outbreaks have been seen in fully immunized
populations,[9]pointingoutthepotentialfailureofvaccines
toconferprotectionfromdisease.Dataalsosuggestthatthere
are limitations to the use of serologic tests for diagnosing
mumps,raisingthequestionofhowtointerpretthosetestsin
the setting of a clinical presentation compatible with mumps
[4].
Pregnant women with mumps face concerns beyond
those of the general population. Ornoy reported that mumps
infection in pregnancy increased the risk of embryonic and
fetal death as well as spontaneous abortion, but did not seem
to have any relation to fetal congenital anomalies [3]. How-
ever, the patient population that was reviewed was extremely
small. In another study of ﬁve women volunteers who were
scheduled to have second trimester therapeutic abortions,
and who were immunized by the Jeryl-Lynn strain of attenu-
atedmumpsvirus7–10daysbeforetheirscheduledabortion,
mumpsviruswasdetectedin2/5placentasbutinnoneofthe
fetuses [10]. However, it is possible that the interval between
immunization and abortion was too short to allow for viral
replication in fetal organs. Jones et al. addressed the issue of
mumps infection in the perinatal period in 1980 [11]. In that
case series, three women with symptomatic mumps during
labor, with three diﬀerent fetal outcomes, were reported.
One infant had swelling in the parotid area and a positive
mumps skin test at 42 days of age. A second infant developed
pneumonia on day 7 and had to be hospitalized and intu-
bated. That infant subsequently presented with upper res-
piratory tract complications in the ﬁrst year of life. The
third infant had no evidence of mumps and never developed
symptoms. In all three of these cases, infants reached normal
developmentalmilestonesandhadnofurthercomplications.
More serious complications of mumps infection include
aseptic meningitis (occurring asymptomatically in 50–60%
of cases), symptomatic meningitis (up to 15%), encephalitis
(less than 2 per 100,000), myocarditis (3–15%), pancreatitis
(2–5%), deafness (1 in 20,000), and inﬂammation of ovaries
(up to 5%), arthritis, and nephritis, which are less common,
and on average one death per year from mumps from 1980–
1999 [12]. Desai described a primigravida at term with
rupture of membranes and acute renal failure with a clinical
diagnosisofmumps.Thepatientwasmanagedbyimmediate
delivery by cesarean section and given IV steroids as well as
diuretics for the management of suspected mumps nephritis.
The patient recovered but the neonate expired soon after
delivery, and no investigation was performed to determine
if the neonate had mumps [13].
Despite these risks, pregnant women are frequently un-
vaccinated. Haas et al. in 2005 found that current screening
and vaccine programs left pregnant women susceptible to
measles, mumps, and rubella and concluded that there is a
need for a more comprehensive viral screening program to
ensure immunity and adequate vaccination, and to establish
better care in the prenatal period. In their study, 16.3% of
women were susceptible to mumps infection, and one third
of women in their study were found to lack immunity to
rubella, rubeola or mumps [14]. Coonrod et al. have sug-
gested that immunizations be a part of preconception care
[15]. Hepatitis B and MMR vaccine are already recommend-
ed as part of preconception care, because of the beneﬁt of
giving these immunizations before pregnancy, and their
eﬀectives in preventing maternal disease and vertical trans-
mission [15].
Mumps infection can be diagnosed by isolation of
mumps virus or nucleic acid from clinical specimens, by ob-
serving a rise in mumps-speciﬁc immunoglobulin titers be-
tween acute and convalescent serum samples or by a positive
serologic test for mumps IgM in serum or saliva [16].
Mumps-speciﬁc IgM can be detected on the 11th day after
exposure and is usually present by the time clinical illness
develops. IgG levels oﬀer evidence of prior exposure but do
not correlate well with immunity [17]. Currently, the gold
standard for diagnosis of mumps is viral culture [9]. How-
ever, that test is not readily available for clinical use.
In addition to the diﬃculty in making the diagnosis of
mumps in the clinical setting, another issue raised by our ex-
perience was the need to address the infectious nature of
the illnesses and the susceptibility of other patients and staﬀ
to potentially infectious source patients. CDC guidelines
advise placing patients with suspected infection on droplet
precaution. What is less clear is how to manage patients
with symptoms compatible with mumps infection who have
had two MMR vaccines in the past, and who have IgG anti-
body. As noted above, the vaccine is imperfect (76–95%
eﬀective), and circulating IgG levels are not reliable markers
ofadequateimmunity[18].IgMisalsounreliable,sincethere
might only be a transient peak in IgM in the presence of
IgG such that the absence of IgM does not preclude acute
infection.Becauseoftheseuncertainties,theputativemumps
patients had a disruptive impact on staﬃng. Healthcare
workers with a history of vaccination or evidence of IgG
antibody to mumps were regarded as immune. However,
some individuals can be IgG negative even after vaccination,
and since evidence of mumps vaccination status is not a con-
dition of employment, many physicians and nurses were
unaware of their status. Among staﬀ without serologic evi-
dence of immunity, evidence of two MMR vaccines or a
physician note conﬁrming prior mumps infection were ac-
cepted as evidence of immunity. Healthcare workers without
such documentation were removed from the workplace for
theentireincubationperiod,12–25daysafterexposure.Dur-
ing a brief period, the NYC DOHMH did not consider a
positive IgG as evidence of immunity, and these employees
were also removed from the workplace.
When mumps becomes endemic in a community, preg-
nant patients being seen in a hospital or clinic should be rou-
tinely asked about mumps exposure and symptoms. If infec-
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in isolation and put on droplet precautions. It may also be
worth incorporating screening for mumps immunity at the
time of employment oﬀering nonimmune individuals addi-
tional booster vaccines.
Finally, in a mumps advisory disseminated a few months
after the epidemic, the NYC DOHMH suggested that the
diagnosis of mumps should be based on clinical manifesta-
tions, particularly parotitis. It was also mentioned that pa-
tients who had been immunized with mumps vaccine can
still be infected with mumps, and the diagnosis should not
be ruled out on the basis of negative IgM. The recom-
mendations that the NYC DOHMH made, and which are
now followed at our institution, and which we believe
would be useful on any obstetrical service facing a similar
circumstance are the following:
(1) Patients who present with parotitis, jaw pain, fever,
or orchitis should be isolated for ﬁve days, and
mumps serology should be sent unless another cause
of parotitis is determined
(2) Patients who might have been in close contact with
mumps virus should be excluded from work or
schoolfor25daysafterexposureoruntiltheyarevac-
cinated
(3) Health care workers should be given appropriate
attire (mask) when working with suspected mumps
patients.Exposedhealthcareworkerswhohavenever
been vaccinated or who do not have evidence of
mumpsimmunityshouldstayathomefromdays12–
25 after exposure, even if they receive a ﬁrst dose of
vaccine after exposure. Workers who have received
one dose of vaccine in the past could continue work-
ing,butshouldgetaseconddoseoftheMMRvaccine
28 days after the ﬁrst one. Health care workers with
serologic evidence of immunity can continue their
daily work duties despite their exposure to virus [7].
Theserecommendationscallforroutinelyusingdiagnos-
tic tests in nonepidemic situations. However, in an epidemic
situation, such as the one we describe, it became apparent
that tests had limitations, including the turnaround time
needed for obtaining results. Thus, decisions about hospital
i n f e c t i o nc o n t r o lm a yo f t e nh a v et ob em a d eb e f o r er e s u l t s
become available.
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